Consequently, we deduced that ARSD may be a novel downstream target gene of ERα, and three TFs, FOXA1, GATA3, and ERα, may form a functional enhanceosome to drive the transcription of ARSD in MCF-7 BC cell. The gene discussed is ARSD; the disease is breast cancer.